Dispositivo de Oclusão do Apêndice Atrial Esquerdo
Artigos Clínicos Publicados
Literatura Científica - Materiais e Resumos Relacionados (em Inglês)
Reddy V Y et al, Safety of Percutaneous Left Atrial Appendage Closure: Results from the WATCHMAN Left Atrial Appendage System for Embolic Protection in Patients With AF (PROTECT AF) Clinical Trial and the Continued Access Registry, Circulation AHA January 2011.
Holmes D R et al, Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomized non-inferiority trial, Lancet 2009;374:534-42.
Sick P B et al, Initial Worldwide Experience with the WATCHMAN Left Atrial Appendage System for Stroke Prevention in Atrial Fibrillation. J Am Col Cardiol 2007;49:1490-5.
Holmes DR, Schwartz R S, Left Atrial Appendage Occlusion Eliminates the Need for Warfarin. Circulation 2009;120:1919-1926.
Wolf P.A., Abbott R.D., Kannel W.B. Atrial Fibrillation as an Independent Risk Factor for Stroke: The Framingham Study. Stroke 1991, 22(8):983-988.
Blackshear J.L., Odell J.A., Thoracoscopic Obliteration of the Appendage to Reduce Stroke in Cardiac Surgical Patients with Atrial Fibrillation. Annals of Thoracic Surgery, 1996;61:755-759.